Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study - Concepedia

Concepedia

Publication | Closed Access

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

1.1K

Citations

29

References

2008

Year

Daniel J. Drucker, John B. Buse, Kristin Taylor, David M. Kendall, Michael Trautmann, Dongliang Zhuang, Lisa A. Porter

Non-pharmacological InterventionDiabetes ManagementInsulin ManagementDiabetesType 2Non-inferiority StudyWeekly VersusPharmacotherapyDiabetes MellitusMedicine

References

	Year	Citations

Page 1